BioSante CEO Stephen Simes: Leveraging Libido
How does BioSante, a small pharmaceutical company that took in $2.5 million in revenue in 2010, expect to compete in the multi-billion dollar pharma industry? By being patient, outlasting the pharma giants, and introducing a new drug to fill a gap in the market.